Oncology & Cancer

FDA approves pembrolizumab plus axitinib for advanced RCC

(HealthDay)—The combination of pembrolizumab and axitinib has been approved as a first-line treatment in advanced renal cell carcinoma (RCC), the U.S. Food and Drug Administration announced Friday.

Vaccination

Shingles vaccine: Should I get it?

Question: What are my options for the shingles vaccine? If I've already had shingles, should I get the vaccine so that I don't get shingles again?

Inflammatory disorders

New discovery solves problem of anti-inflammatory substance

There have been great expectations regarding the production of a drug to block the enzyme LTA4 hydrolase, which plays a key role in the body's inflammatory response. However, in clinical trials, such molecules have proven ...

Diseases, Conditions, Syndromes

Temporary tattoos may leave permanent damage

(HealthDay)—As thousands of college students head to sunny spots for spring break, getting temporary tattoos may seem like a fun thing to do. But the U.S. Food and Drug Administration warns that they can cause blisters ...

Genetics

How genetics could make medicine efficient and personalized

Upbringing and circumstance—and the consequences of a lifetime of decisions—all shape us to varying degrees. And the environment undoubtedly plays some role. But, at the core of it all is our genetics, the foundational ...

page 5 from 29